October 2012 Briefing - HIV & AIDSLast Updated: November 01, 2012.
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for October 2012. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
U.S. Medicare Spending on Elderly Has Outpaced Canada's
TUESDAY, Oct. 30 (HealthDay News) -- U.S. Medicare spending on the elderly has grown nearly three times faster than its Canadian counterpart, according to a study published online Oct. 29 in the Archives of Internal Medicine.
Genuine Very Large Effects in Trials Rare in Medicine
TUESDAY, Oct. 23 (HealthDay News) -- Large treatment effects are most likely to be found in small studies, with the effect diminishing with additional trials, according to research published in the Oct. 24 issue of the Journal of the American Medical Association.
Vaccination Strategy Effective Against Genital Herpes
THURSDAY, Oct. 18 (HealthDay News) -- A new vaccination strategy is effective against genital herpes and possibly other sexually transmitted infections, according to an experimental study published online Oct. 17 in Nature.
Return to Work Difficult for Doctors on Sick Leave
THURSDAY, Oct. 18 (HealthDay News) -- Returning to work after a prolonged sick leave for physical or mental health problems, or drug or alcohol problems, is difficult for doctors, who describe self-stigmatization and fear a negative response on their return to work, according to a study published online Oct. 15 in BMJ Open.
High-Dose Vitamins Don't Halt HIV Progression, Death
TUESDAY, Oct. 16 (HealthDay News) -- High-dose vitamin supplementation does not reduce HIV disease progression or death among HIV patients initiating highly active antiretroviral therapy (HAART) in Tanzania, according to a study published in the Oct. 17 issue of the Journal of the American Medical Association.
Social Media Influences Youth Sexual Behavior in Short Term
THURSDAY, Oct. 11 (HealthDay News) -- Social media can be an efficacious vehicle for delivering messages regarding the prevention of sexually transmitted infections (STIs), according to a study published online Oct. 9 in the American Journal of Preventive Medicine.
HIV Diagnosis in Hispanics or Latinos Varies Geographically
THURSDAY, Oct. 11 (HealthDay News) -- The distribution of new diagnoses of HIV among Hispanics or Latinos in the United States and Puerto Rico varies by region, as do characteristics of those infected, according to research published in the Oct. 12 issue of the U.S. Centers for Disease Control and Prevention's Morbidity & Mortality Weekly Report.
HIV Status Doesn't Influence Hodgkin's Lymphoma Outcome
THURSDAY, Oct. 11 (HealthDay News) -- Despite more extensive disease and more adverse prognostic factors, HIV-positive patients with Hodgkin's lymphoma (HL) do not have worse outcomes when treated with doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD), according to research published online Oct. 8 in the Journal of Clinical Oncology.
HIV Mortality Decreasing, but Disparities Persist
TUESDAY, Oct. 9 (HealthDay News) -- HIV death rates decreased from 1993-1995 to 2005-2007, but socioeconomic disparities are increasing, according to a study published online Oct. 8 in the Archives of Internal Medicine.
Large Review Confirms Melanoma Risk Up in Immunosuppressed
TUESDAY, Oct. 9 (HealthDay News) -- Immunosuppressed patients, particularly solid-organ transplant recipients and lymphoma patients, have about a two-fold or higher risk of developing melanoma, according to research published in the October issue of the Mayo Clinic Proceedings.
Anal Cancer Increase Linked to HIV Infection Only in Men
FRIDAY, Oct. 5 (HealthDay News) -- The rising incidence of anal cancer since 1980 in the United States is strongly impacted by HIV infection in men but not women, according to a study published online Oct. 5 in the Journal of the National Cancer Institute.
Opiate Substitution Cuts Risk of HIV for Injection Drug Users
FRIDAY, Oct. 5 (HealthDay News) -- Among people who inject drugs, opiate substitution treatment correlates with more than a 50 percent reduction in the risk of HIV infection, according to research published online Oct. 4 in BMJ.
Limiting the Problem of Missing Data Urged for Clinical Trials
WEDNESDAY, Oct. 3 (HealthDay News) -- Missing data compromise inferences from clinical trials, and due to the problematic nature of compensation with analysis methods, the importance of avoiding missing data in clinical trials is paramount, according to a special report published in the Oct. 4 issue of the New England Journal of Medicine.
Study Probes How Some HIV Patients Resist AIDS
TUESDAY, Oct. 2 (HealthDay News) -- Rare HIV-infected individuals who are able to control the virus, known as elite controllers, generate specific immune responses that correlate with viral control in a monkey model of AIDS, according to a study published online Sept. 30 in Nature.
Observation Units Could Save $3.1 Billion Nationally Per Year
TUESDAY, Oct. 2 (HealthDay News) -- The addition of observation units to U.S. hospitals which do not currently have them in place could save $3.1 billion nationally per year in health care costs, according to a study published online Sept. 26 in Health Affairs.
Higher Risk of Esophageal, Stomach Cancer With AIDS
MONDAY, Oct. 1 (HealthDay News) -- There is an increased risk of esophageal and stomach cancers among people with AIDS, according to a study published in the October issue of Gastroenterology.
Patients Benefit From Access to Physician Notes
MONDAY, Oct. 1 (HealthDay News) -- Patients report clinically relevant benefits and minimal concerns, while doctors do not experience negative consequences, from allowing patient access to visit notes, according to a study published in the Oct. 1 issue of the Annals of Internal Medicine.
|Previous: October 2012 Briefing - Gastroenterology||Next: October 2012 Briefing - Infectious Disease|
Reader comments on this article are listed below. Review our comments policy.